Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Spark Therapeutics Now Targets 2017 For US Approval Of First Retinal Gene Therapy

Aug 11 2016

• By John Davis

Vision — • Source: Shutterstock

Related Content

EU's CHMP Clears Europe's First Gene Therapy, UniQure's Glybera

Jul 20 2012

Spark Restores Vision In Phase III; CEO Hopes To Lead Gene Therapy Field

Oct 06 2015

Can FDA's Breakthrough Program Finally Midwife Gene Therapy?

Aug 01 2016

Related Companies

Spark Therapeutics, Inc.

uniQure N.V.

GSK plc

Pfizer Inc.

Additional Topics

Research & Development Regenerative Medicine Ophthalmic BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window